Unlocking Europe's Biotech Market: Licensing, Commercialization & Market Access | Webinar

An Expert Conversation on Bringing Innovative Therapies to Europe

Europe offers significant opportunities for U.S. biotech and pharmaceutical companies seeking licensing agreements, strategic partnerships, and pathways to commercialization. However, decisions made during early drug development can significantly influence future European licensing opportunities, commercialization strategies, and asset value.

When should companies begin planning for Europe? How do regulatory, pricing, and reimbursement considerations influence licensing and commercialization strategies? And what should companies understand about the differences among Europe’s major pharmaceutical markets?

Join the Economic Development Partnership of North Carolina (EDPNC) and the North Carolina Biotechnology Center for a GLOBE webinar featuring experts from Switzerland and Germany. Following a brief introductory presentation, a moderated fireside chat will explore the key business considerations, strategies, and opportunities for bringing innovative therapies to Europe.

Topics will include:

• Planning for Europe: Key considerations at different stages of drug development, from preclinical research through commercialization.
• Licensing and asset value: How European market considerations influence licensing strategies, partnerships, and asset value.
• Navigating European markets: Important similarities and differences among Germany, France, Italy, Spain, and the United Kingdom.
• Switzerland’s strategic role: Advantages and trade-offs of Swiss pharmaceutical partnerships and market entry compared with other European markets.
• Emerging policy developments: Potential implications of the EU Joint Clinical Assessment framework and evolving U.S. Most-Favored-Nation (MFN) drug pricing policies.
• Avoiding common pitfalls: Practical guidance and next steps for companies exploring European opportunities.
• Additional Opportunity: Learn about EDPNC’s April 2027 biotech trade mission to Switzerland and Germany.

Who Should Attend

Biotech and pharmaceutical founders, executives, and business development teams interested in European licensing, strategic partnerships, and commercialization opportunities, including companies in preclinical and clinical development.

Featured Speakers

Thomas A. Frei, Executive Client Director, Athagoras | Basel, Switzerland

Tilo Mandry, Lead International Liaison Manager, IGES | Berlin, Germany

Moderator

Melissa McGurk, Senior International Trade Manager Life Sciences, Economic Development Partnership of North Carolina / GLOBE

Presented through GLOBE, an international business life sciences collaboration of the North Carolina Biotechnology Center, Economic Development Partnership of North Carolina, U.S. Commercial Service North Carolina, and Small Business & Technology Development Center.

Register in advance for this meeting:

SAve your spot              View All Export Events

After registering, you will receive a confirmation email containing information about joining the meeting.